Deprescribing Proton Pump Inhibitors in an Academic, Primary Care Clinic Quality Improvement Project

被引:14
|
作者
Nallapeta, Naren [1 ]
Reynolds, Jessica L. [2 ]
Bakhai, Smita [3 ]
机构
[1] Univ Buffalo State Univ New York, Dept Internal Med, Buffalo, NY 14215 USA
[2] Univ Buffalo State Univ New York, Dept Med, Buffalo, NY 14215 USA
[3] Univ Buffalo State Univ New York, ECMC, Dept Internal Med, Suite 15,462 Grider St, Buffalo, NY 14215 USA
基金
美国国家卫生研究院;
关键词
proton pump inhibitors; quality improvement; evidence-based guidelines; deprescribing PPI; primary care; inappropriate use of PPI; COMMUNITY-ACQUIRED PNEUMONIA; LONG-TERM USE; RISK; THERAPY; INFECTION; BENEFITS; OVERUSE; NEED;
D O I
10.1097/MCG.0000000000001317
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Goal: The goal of this study was to reduce the percentage of inappropriately prescribed proton pump inhibitors (PPIs) in patients aged 50 and older from 80% (baseline) to 60% within 12 months in an academic, internal medicine clinic. Background: The use of PPIs has increased drastically worldwide. Internal medicine clinic patients had inappropriate use of PPIs for an average of 4 to 5 years. Study: A multidisciplinary quality improvement team used the Plan-Do-Study-Act Model of health care improvement and performed a root cause analysis to identify barriers to inappropriate use of PPIs. The outcome measure was the percentage of patients inappropriately prescribed PPI. Process measures were completion rates of PPI risk assessment and esophagogastroduodenoscopy. Interventions included the creation of customized electronic health record templates and education to providers and patients. Analysis was performed using monthly statistical process control charts. Results: The average rate of PPI discontinuation was 51.1% (n=92/180), which corresponds to 30.0% inappropriate PPI usage within 12 months. The mean PPI discontinuation rate in the 1-year prestudy, study and 6 months poststudy period was 2.0%, 32.0%, and 49.7%, respectively. The mean esophagogastroduodenoscopy completion rate was 49.8% from the baseline of Conclusions: We achieved a statistically significant and sustainable reduction of inappropriate PPI use to 30% from the baseline rates of 80% and surpassed our goal within 12 months. This quality improvement was unique as no pharmacy personnel was utilized in this process. The multifaceted strategies in a safety-net internal medicine clinic resulted in successful deprescribing of PPI and can be replicated in other setting.
引用
收藏
页码:864 / 870
页数:7
相关论文
共 50 条
  • [31] Deprescribing Strategies: A Prospective Study on Proton Pump Inhibitors
    Calvini, Giulia
    Baiardi, Giammarco
    Mattioli, Francesca
    Milano, Giulia
    Calautti, Francesca
    Zunino, Alessia
    Fraguglia, Carla Elda
    Caccavale, Fabio
    Lantieri, Francesca
    Antonucci, Giancarlo
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (08)
  • [32] Timely Administration of Proton Pump Inhibitors in an Urban Community Hospital Setting: A Quality Improvement Project
    Shahnazarian, Vahe
    Aamar, Ali
    Kolli, Sindhura
    Nagaraj, Savitha
    Ramai, Daryl
    Reddy, Madhavi
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S1728 - S1728
  • [33] Patient and Provider Perspectives on Deprescribing Proton Pump Inhibitors
    Ikeji, Chisom
    Williams, Anne
    Hennawi, George
    Brandt, Nicole J.
    JOURNAL OF GERONTOLOGICAL NURSING, 2019, 45 (10): : 9 - 17
  • [34] Deprescribing Proton Pump Inhibitors: Updated Clinical Guidelines
    Gaulke, Carolyn
    JNP- THE JOURNAL FOR NURSE PRACTITIONERS, 2024, 20 (09):
  • [35] Deprescribing in a Long Term Care Patient Population: A Quality Improvement Project
    Schmees, M.
    Ruff, G.
    Drost, J.
    Kayani, N.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2024, 72 : S175 - S175
  • [36] Evidence-based deprescribing of proton pump inhibitors in long-term care
    Sluggett, Janet K.
    Hendrix, Ivanka
    Bell, J. Simon
    RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY, 2018, 14 (02): : 124 - 126
  • [37] Are the deprescribing guidelines for proton pump inhibitors in palliative care applicable? A monocentric observational study
    Evin, Adrien
    Denis, Claire
    Nizet, Pierre
    Denis, Roxane
    Lannes, Morgane
    Victorri-Vigneau, Caroline
    Huon, Jean Francois
    BMJ SUPPORTIVE & PALLIATIVE CARE, 2023, 13 (E3) : e928 - e932
  • [38] PROTON PUMP INHIBITORS MARKET IN PRIMARY CARE SETTING
    Cammarota, S.
    De Portu, S.
    Citarella, A.
    Menditto, E.
    Cuomo, R.
    VALUE IN HEALTH, 2008, 11 (06) : A531 - A531
  • [39] Inappropriate prescribing of proton pump inhibitors in primary care
    Batuwitage, Bisanth Thushila
    Kingham, Jeremy G. C.
    Morgan, Nia Emma
    Bartlett, Ruth Louise
    POSTGRADUATE MEDICAL JOURNAL, 2007, 83 (975) : 66 - 68
  • [40] A Quality Improvement Project to Increase Bariatric Surgery Referrals at an Urban Primary Care Clinic
    Buckley, Megan C.
    Bhandari, Peter
    Sharma, Priyanka
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S1054 - S1054